SecBot SecBot

NATR

NATURES SUNSHINE PRODUCTS INC
Nasdaq· Pharmaceutical Preparations· Inc. UT· CIK 0000275053 Biotech & Drug Discovery
$12.39 +0.12 (+0.98%)
Oct 27 4:00 PM ET · prev $12.27
Market cap
$213.8M
Micro cap
Consensus
Buy
88% Buy or better · 8 analysts
Median target
$30.50
+146% · range $25.00–36.00
Next earnings
Nov 4
in 8 days · EPS est. $0.27
1 year
−10.5%
from $13.85 · Oct 28
30 days
−3.4%
from $12.83
52-week range
$12.15–27.80
−55% from high · low Oct 23
Avg volume 20D
104.1K
shares / day
Short interest
918.7K
≈5.2% of shares · +7.2%
Days to cover
8.2
at average volume
Insider net
+$1.9M
1 buyer · 4 sellers · since May 5
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BULLISH 5 reports · 90 days
Balance 0 bearish · 2 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 1/5 ·Next Earnings date, Nov 4, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $2.6M at an average $16.19. 4 insiders sold $742.4K. Price is 23% below their cost.

  • InstitutionsBULLISH

    Q2 2026: 18 added (0 new), 11 trimmed or exited.

  • AnalystsBULLISH

    7 of 8 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.330 → $0.265 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest +7.2% to 918.7K shares. 8.2 days to cover, ≈5.2% of shares.

  • TrendDOWNTREND

    6% below its 50-day average. New closing low $12.15 on Oct 23.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD PORTFOLIO MANAGEMENT LLCDOUBLED289,408$6.3M
Man Group plcDOUBLED126,873$2.8M
PANAGORA ASSET MANAGEMENT INCDOUBLED111,347$2.4M
SEI INVESTMENTS COTRIM73,280$1.6M
LOS ANGELES CAPITAL MANAGEMENT LLCDOUBLED60,502$1.3M
Trexquant Investment LPTRIM47,606$1.0M
FMR LLCDOUBLED46,209$1.0M
UBS Group AGADD35,414$772.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

8 analysts
Buy 88% rate it Buy or better
Strong Buy2Buy5Hold1Sell0Strong Sell0
12-month targets · 2 analysts

Price is below the lowest target. Median implies +146%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Aug 10, 2026DA Davidson
MAINTAIN
MAINTAINBuy
Jul 30, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
May 11, 2026DA Davidson
MAINTAIN
MAINTAINBuy

Washington

Corporate Lobbying

8 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$2.6M
bought · 1 insider
$742.4K
sold · 4 insiders
−23.5%
vs their $16.19 cost
DateInsiderTypeValue
Sep 2, 2026
Perkins Ruth Ann
EVP, Chief Financial Officer
AWARD36,049 sh
Sep 2, 2026
Perkins Ruth Ann
EVP, Chief Financial Officer
AWARD39,384 sh
Sep 1, 2026
Lanoy Jonathan David
SVP, Chief Accounting Officer
AWARD7,210 sh
Aug 17, 2026
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
10%+ Owner
BUY$293.8K
Aug 10, 2026
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
10%+ Owner
BUY$13.7K
Aug 10, 2026
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
10%+ Owner
BUY$160.1K
Aug 10, 2026
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
10%+ Owner
BUY$267.5K
Aug 10, 2026
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
10%+ Owner
BUY$206.3K

Earnings setup

Estimates
Nov 4
reports in 8 days
$0.27
EPS estimate, this quarter
−20%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.27$0.21–$0.32-19.7%$129.5M
Next Q$0.28$0.26–$0.30+0.0%$126.3M
Current FY$1.08$1.03–$1.13-10.4%$495.7M
Next FY$1.23$1.08–$1.38-9.2%$519.2M

Short side

FINRA· Oct 15, 2026
918,670
shares short
+7.2%
vs prior settlement
8.2
days to cover
≈5.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 27, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 21, 2026 SEC
Nature's Sunshine Products, Inc. announced it will host a conference call on November 4, 2026 to discuss its Q3 2026…
PRESS-RELEASE — Impact 1/10
Oct 21, 2026 Earnings
Nature’s Sunshine Sets Third Quarter 2026 Conference Call for Wednesday, November 4, 2026, at 5:00 p.m. ET
LEHI, Utah, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (
Sep 2, 2026 Insider
Perkins Ruth Ann was granted 36,049 shares
EVP, Chief Financial Officer
Sep 2, 2026 Insider
Perkins Ruth Ann was granted 39,384 shares
EVP, Chief Financial Officer
Sep 1, 2026 Insider
Lanoy Jonathan David was granted 7,210 shares
SVP, Chief Accounting Officer
Aug 19, 2026 SEC
A 10% owner, Prescott Group Capital Management, purchased $941K of NATR stock over a week, including $294K at the…
INSIDER-BUY — Impact 5/10
Aug 3, 2026 Press
Nature's Sunshine appointed Janine Weber as EVP and President, North America, effective August 10, 2026. Weber brings…
Impact 2/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

SecBot reports

10 filings · 2 press releases · 3 bullish · 0 bearish · 7 neutral
All NATR filing & press-release reports (12)